Our study revealed that low SNX29 expression was strongly associated with ICB response in various cancers, including BLCA, GBM, HNSC, LAML, LUAD, THCA, SARC, SKCM, THYM and STAD (Fig. 7A–J). Here, SNX29 is linked to bladder transitional cell carcinoma.